Analyst Signal

Abbott Laboratories (ABT) is currently trading at $102.87. Based on 25 Wall Street analysts, the average target price is $132.28, implying a 28.6% upside. The consensus recommendation is BUY.

ABT

Abbott Laboratories

HealthcareOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$102.87

Avg Target

$132.28

Based on 25 analysts

Analyst Recommendations

Buy (22)Hold (7)Sell (0)

Upside

+28.59%

Market Cap

$178.76B

Financial & Investment Metrics

Next Earnings Date
Apr 16, 2026D-13
P/E Ratio (TTM)27.65
Forward P/E16.85
P/B Ratio3.43
Dividend Yield2.46%
Return on Equity (ROE)12.96%
Operating Margin21.62%
Debt to Equity26.79
Beta (Volatility)0.74
52 Week Range$100.88 - $139.06
LowCurrent: $102.87High

Insider Sentiment Index (Last 6 Months)

Buy vs Sell (Count)

Insider Buys: 14Insider Sells: 7

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Recent Insider Transactions

DateNamePositionTransactionShares
3/23/2026ORVILLE JACOB AOfficerStock Award(Grant) at price 0.00 per share.13,255
3/2/2026MORELAND MARY KOfficerSale at price 115.58 per share.613
3/2/2026SHROFF ERICOfficerSale at price 115.58 per share.709
3/2/2026CUSHMAN ELIZABETH CGeneral CounselSale at price 115.58 per share.263
3/2/2026MORRONE LOUIS HOfficerSale at price 115.58 per share.1,144
3/2/2026SALVADORI DANIEL GESUA SIVEOfficerSale at price 115.58 per share.885
3/2/2026MCCOY JOHN A. JROfficerSale at price 115.58 per share.585
2/24/2026SHROFF ERICOfficerStock Award(Grant) at price 0.00 per share.10,873
2/24/2026CUSHMAN ELIZABETH CGeneral CounselStock Award(Grant) at price 0.00 per share.15,031
2/24/2026MCCOY JOHN A. JROfficerStock Award(Grant) at price 0.00 per share.5,373

Frequently Asked Questions

Q. What is the current target price and upside for ABT?

A. The current target price for Abbott Laboratories is $132.28, which implies a 28.6% upside from the current price of $102.87. This is based on the consensus of 25 Wall Street analysts.

Q. What is the current analyst recommendation for ABT?

A. Currently, there are 6 Strong Buy, 16 Buy, 7 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying ABT stock recently?

A. Over the past 6 months, there have been 14 insider buys and 7 insider sells. This can be interpreted as a positive signal.

Other Promising Stocks in Healthcare

ABT (Abbott Laboratories) Stock Analysis | Analyst Signal